Anna Fabisiewicz

8PUBLICATIONS
9CO-AUTHORS
Cancer diagnosisCancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 13, 2025
The Combined Assessment of CTC and ESR1 Status in Liquid Biopsy Samples Enhances the Clinical Value of Prediction in Metastatic Breast Cancer.

Malgorzata Szostakowska-Rodzos, Ewa A Grzybowska, Izabella Mysliwy

|Oct 16, 2024
Improving the Prognostic and Predictive Value of Circulating Tumor Cell Enumeration: Is Longitudinal Monitoring the Answer?

Anna Fabisiewicz, Malgorzata Szostakowska-Rodzos, Ewa A Grzybowska

|Apr 23, 2022
Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer.

Beata Joanna Mossakowska, Somayeh Shahmoradi Ghahe, Dominik Cysewski

|Nov 02, 2018
Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals.

Małgorzata Szostakowska, Alicja Trębińska-Stryjewska, Ewa Anna Grzybowska

|Mar 10, 2018
SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangement.

Małgorzata Szostakowska, Michał Szymczyk, Kalina Badowska

Pageof 2